Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Hongyu Xu, Qinglin Yu, Honglin Zhou, Jin Yang, Nan Zheng, Zhifeng Xu & Jia Su. (2021) Polymorphisms in the GCK gene increase the risk of clopidogrel resistance in stable coronary artery disease (SCAD) patients. Hematology 26:1, pages 447-452.
Read now
Read now
Ramón Cacabelos, Natalia Cacabelos & Juan C. Carril. (2019) The role of pharmacogenomics in adverse drug reactions. Expert Review of Clinical Pharmacology 12:5, pages 407-442.
Read now
Read now
Juan Liu, Zesheng Xu, Ya Li, Shipeng Dai, Junying Liu, Junjun Pan & Yang Jiang. (2019) Comparison between MassARRAY and pyrosequencing for CYP2C19 and ABCB1 gene variants of clopidogrel efficiency genotyping. Molecular Membrane Biology 35:1, pages 1-8.
Read now
Read now
Isabell Bernlochner, Katharina Mayer, Martin Orban, Tanja Morath, Juliane Jaitner, Lisa Rössner, Lisa Gross, Karl-Ludwig Laugwitz, Adnan Kastrati & Dirk Sibbing. (2016) Ticagrelor versus prasugrel in patients with high on-clopidogrel treatment platelet reactivity after PCI: The ISAR-ADAPT-PF study. Platelets 27:8, pages 796-804.
Read now
Read now
Articles from other publishers (7)
Zahra Abdulathim Alhaddad, Hissah Abdullatif AlMousa & Nancy S. Younis. (2022) Pharmacists’ Knowledge, and Insights in Implementing Pharmacogenomics in Saudi Arabia. International Journal of Environmental Research and Public Health 19:16, pages 10073.
Crossref
Crossref
Zhizhang Li, Huayu Jiang, Ying Ding, Dong Zhang, Xiaoguang Zhang, Jie Xue, Ruinan Ma, Liang Hu & Yunhua Yue. (2021) Platelet Endothelial Aggregation Receptor 1 Polymorphism Is Associated With Functional Outcome in Small-Artery Occlusion Stroke Patients Treated With Aspirin. Frontiers in Cardiovascular Medicine 8.
Crossref
Crossref
Dongbiao Yu, Likun Ma, Junling Zhou, Longwei Li, Wu Yan & Xiaofan Yu. (2020) Influence of CYP2C19 genotype on antiplatelet treatment outcomes after percutaneous coronary intervention in patients with coronary heart disease. Experimental and Therapeutic Medicine.
Crossref
Crossref
D. G. Gitelson, A. G. Faibushevich, D. A. Maximkin, G. I. Veretnik, A. E. Vasiliev, E. A. Gitelzon, D. A. Rogov & K. I. Danishian. (2019) Effectiveness of personalized antiplatelet therapy in patients undergoing coronary stenting: meta-analysis. Complex Issues of Cardiovascular Diseases 8:4, pages 26-36.
Crossref
Crossref
Renata C. Costa de Freitas, Raul H. Bortolin, Mariana B. Lopes, Letícia Tamborlin, Letícia Meneguello, Vivian N. Silbiger, Rosario D. C. Hirata, Mário H. Hirata, Augusto D. Luchessi & André D. Luchessi. (2017) Modulation of miR-26a-5p and miR-15b-5p Exosomal Expression Associated with Clopidogrel-Induced Hepatotoxicity in HepG2 Cells. Frontiers in Pharmacology 8.
Crossref
Crossref
Valon Krasniqi, Aleksandar Dimovski, Hasime Qorraj Bytyqi, Aleksandar Eftimov, Livija Šimičević & Nada Božina. (2017) Genetic polymorphisms of CYP2C9, CYP2C19, and CYP3A5 in Kosovar population. Archives of Industrial Hygiene and Toxicology 68:3, pages 180-184.
Crossref
Crossref
Renata Caroline Costa de Freitas, Raul Hernandes Bortolin, Mariana Borges Lopes, Mario Hiroyuki Hirata, Rosario Dominguez Crespo Hirata, Vivian Nogueira Silbiger & André Ducati Luchessi. (2016) Integrated analysis of miRNA and mRNA gene expression microarrays: Influence on platelet reactivity, clopidogrel response and drug-induced toxicity. Gene 593:1, pages 172-178.
Crossref
Crossref